Increased Serum Retinol-Binding Protein 4 Concentrations in Women With Gestational Diabetes Mellitus

Abstract

The authors hypothesized that serum retinol-binding protein 4 (RBP4) concentrations will be higher in gestational diabetes mellitus (GDM) subjects. This study tested both women with GDM and healthy pregnant women and correlated their serum RBP4 concentrations with body mass index (BMI) and a variety of other parameters. Also, since there is no information on the relationship between RBP4 concentrations in maternal and fetal serum, this study measured these at delivery and examined whether there were correlations between the cord serum RBP4 levels and maternal serum RBP4 concentrations, neonatal birth weights, and gestational age at delivery. A total of 40 women were evaluated: 20 women with GDM and 20 healthy pregnant women to serve as control subjects. Serum RBP4 concentrations were analyzed with the use of an enzyme-linked immunosorbent assay kit. Serum RBP4 concentrations at glucose challenge test (GCT) were significantly higher in the GDM group (42.4 ± 13.8 ng/mL) than in the healthy control group (32.0 ± 8.7 ng/mL; P = .007). BMI at GCT (P = .003) and GDM/no GDM (P = .014) were significantly correlated to serum RBP4 concentrations at GCT by multiple linear regression analysis. In GDM subjects, serum RBP4 concentrations immediately after delivery were significantly lower than those at GCT (30.1 ± 11.0 ng/mL, 42.4 ± 13.8 ng/mL; P < .001), but there was no such difference in normal subjects (30.9 ± 10.0 ng/mL, 32.0 ± 8.7 ng/mL; P = .581). Cord serum RBP4 concentrations were significantly lower than maternal serum RBP4 concentrations at delivery (10.9 ± 3.8 ng/mL, 30.5 ± 10.4 ng/mL; P < .001). Only fetal birth weight (P = .049) was independently related to cord serum RBP4 concentrations at delivery by multiple linear regression analysis. This study found increased serum RBP4 concentrations at GCT in GDM subjects, and GDM was significantly correlated to serum RBP4 levels after adjustment for the effect of BMI. Lower RBP4 concentrations were found at delivery in GDM subjects. Maternal serum RBP4 concentrations were significantly higher than cord serum RBP4 concentrations, and fetal birth weights were independently correlated to cord serum RBP4 concentrations. These findings may indicate that RBP4 plays a role in the pathogenesis of GDM. However, further experiments are required to clarify this role and find a possible regimen for GDM treatment.

Keywords

RBP4 GDM BMI fetal birth weights

Get full access to this article

View all access options for this article.

References

Quadro L. , Hamberger L. , Colantuoni V. , Gottesman ME , Blaner WS Understanding the physiological role of retinol-binding protein in vitamin A metabolism using transgenic and knockout mouse models. Mol Aspects Med. 2003;24:421-430.

Tsutsumi C. , Okuno M. , Tannous L. , et al. Retinoids and retinoid-binding protein expression in rat adipocytes . J Biol Chem. 1992;267:1805-1810.

Meigs JB , Panhuysen CI , Myers RH , Wilson PW , Cupples LA A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. Diabetes. 2002;51:833-840.

Duggirala R. , Blangero J. , Almasy L. , et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans . Am J Hum Genet. 1999;64:1127-1140.

Graham TE , Yang Q. , Bluher M. , et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354:2552-2563.

Kahn BB Dietary regulation of glucose transporter gene expression: tissue specific effects in adipose cells and muscle. J Nutr. 1994;124:1289S-1295S.

Muoio DM , Newgard CB Metabolism: A is for adipokine. Nature. 2005 ;436:337-338.

McGarry JD Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7-18.

American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol. 2001 ;98:525-538.

10.

Linne Y. , Barkeling B. , Rossner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG. 2002;109:1227-1231.

11.

Garvey WT , Maianu L. , Zhu JH , Hancock JA , Golichowski AM Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes: heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters . Diabetes. 1993;42:1773-1785.

12.

Yang Q. , Graham TE , Mody N. , et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005 ;436:356-362.

13.

Endo S. , Maeda K. , Suto M. , et al. Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus. Gynecol Endocrinol. 2006;22:343-349.

14.

Burrow GN , Duffy TP Medical Complications During Pregnancy. 5th ed. Philadelphia, Pa: W. B. Saunders; 1999:47.

15.

Cunningham FG , MacDonald PC , Gant NF , et al, eds. Williams' Obstetrics. 20th ed. Norwalk, Conn: Appleton & Lange; 1997.

16.

Quadro L. , Blaner WS , Salchow DJ , et al. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J. 1999 ;18:4633-4644.

17.

Leturque A. , Ferre P. , Burnol AF , Kande J. , Maulard P. , Girard J. Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats. Diabetes. 1986;35:172-177.

18.

Sivitz WI , DeSautel SL , Kayano T. , Bell GI , Pessin JE Regulation of glucose transporter messenger RNA in insulin-deficient states . Nature. 1989;340:72-74.